|
|
||||||||
Letters |
a Author for correspondence. Fax 31 243541743; e-mail R.deKeijzer{at}ckcl.azn.nl
Central Clinical Chemical Laboratory, University Hospital St. Radboud Nijmegen 564 CKCL, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
To the Editor:
We wish to comment on the Technical Brief of Lynch et al. (1), who reported overestimation of methemoglobin concentrations in neonatal samples containing fetal hemoglobin and analyzed with the Chiron 800 system CO-oximeter. Overestimation of methemoglobin in the presence of fetal hemoglobin may have serious implications, with the possibility of premature termination of nitric oxide treatment. In our hospital, >1000 methemoglobin analyses are performed annually on request of our neonatal intensive care unit. These measurements have been performed with a CIBA Corning 270 CO-oximeter and, at present, are also performed with a Chiron 865 blood gas analyzer equipped with a CO- oximetry module (Chiron Diagnostics NV).
We decided to investigate this alarming report and used both analyzers
to measure methemoglobin concentrations in three sets of samples. The
first set consisted of 10 samples from our neonatology department. In
these samples, the concentration of fetal hemoglobin was 65% or
higher. The second and third sets of samples consisted of adult blood
and umbilical cord blood, respectively, collected in heparin-containing
tubes and divided into two portions. In one portion of each
sample, 100% methemoglobin was obtained by adding potassium nitrite
(2). The other portion was not treated (<2%
methemoglobin). All portions were washed with saline several times and
subsequently used to produce samples with nominal percentages of
methemoglobin of 225%. Samples were measured within 2 min on
both blood gas analyzers. The results are given in Table 1
.
|
In the samples from neonates, no statistical differences between the methemoglobin percentages mea-sured with the Corning 270 and the Chiron 865 analyzer were observed (paired t-test, P <0.05). The results obtained for adult blood and umbilical cord blood revealed that measurement of 5% methemoglobin or less was not markedly influenced by the presence of fetal hemoglobin on both analyzers. Above 10% methemoglobin, the Corning 270 blood gas analyzer has a tendency to underestimate the amount of methemoglobin compared with the Chiron 865 analyzer. This, however, was not influenced by the presence or absence of fetal hemoglobin because the discrepancy was present in adult blood as well as umbilical cord blood. These findings were also reported by Lynch et al. (1).
The divergence between our results and those of Lynch et al. in the low methemoglobin range (<5%) may be explained by the different software versions that were used. The analyzer used by Lynch et al. was equipped with software that uses 10 wavelengths to calculate the various hemoglobin fractions. The new software program (Ver. 4.4c) implemented in our Chiron 865 blood gas analyzer uses 40 wavelengths, including wavelengths in the optimal region for the measurement of methemoglobin.
We conclude that the Chiron 865 analyzer equipped with the 40-wavelength software (Ver. 4.4c) is suitable for measuring methemoglobin concentrations in the clinically relevant range, even in samples with high concentrations of fetal hemoglobin.
Acknowledgments
We thank H.E. Aaldring for expert technical support.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |